Worthington Mark — SEC Form 4 filings
SEC reporting owner CIK 1861464. 11 Form 4 filings on record with FilingPulse; latest filed 2026-04-13.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-16 to 2026-04-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 24,177 shares, $28,890 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 1,328 shares @ $5.37 ($7,131) in LeonaBio, Inc., filed 2026-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | GENERAL COUNSEL and CCO | 11 | — | 6 legs · 24,177 sh · $28,890 | 20 |
Form 4 filings — Worthington Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-13 | 4 | LeonaBio, Inc. (LONA) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | LeonaBio, Inc. (LONA) | Option exercise (M): 5,726 @ $0 · Sale (S): 1,328 @ $5.37 · Option exercise (M): 5,726 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Athira Pharma, Inc. (ATHA) | Option exercise (M): 3,667 @ $0 · Sale (S): 876 @ $6.88 · Option exercise (M): 3,667 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 34,358 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Athira Pharma, Inc. (ATHA) | Option exercise (M): 36,666 @ $0 · Sale (S): 8,526 @ $0.29 · Option exercise (M): 36,666 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 85,895 (derivative) @ $0 · Grant/award (A): 57,263 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 3,651 @ $0.55 · Option exercise (M): 36,667 @ $0 · Sale (S): 8,510 @ $0.56 · Option exercise (M): 36,667 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 110,000 (derivative) @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 10,000 @ $1.34 · Grant/award (A): 10,000 @ $0 · Sale (S): 2,525 @ $0.57 | EDGAR |
| 2024-02-16 | 4/A | Athira Pharma, Inc. (ATHA) | Grant/award (A): 7,767 @ $2.41 · Grant/award (A): 10,000 @ $0 · Sale (S): 2,412 @ $2.91 | EDGAR |
| 2024-02-16 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861464 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →